|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 27, 2016 ) According to the report Preclinical In-vivo Imaging Market, published by Market Data Forecast, the global market is projected to reach USD 1004.05 Million by 2021, at a CAGR of 6.15% from 2016 to 2021.
View Report at http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Preclinical in-vivo imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes.
Get free sample report at http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/request-sample
Development of technologically advanced hybrid preclinical imaging systems and growing acceptance of preclinical imaging as a legitimate drug development tool are the factors that are driving the market growth globally. Growing number of CROs in emerging markets is attracting companies to invest in those region.
Request Customization at http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/customize-report
Global Market for Preclinical in-vivo imaging is segmented based on Type and Product into further sub-segments as follows:
1. By Modality
•Optical imaging
oBioluminescence/fluorescence imaging systems
oStandalone fluorescence imaging systems
oOptical + X-ray/optical + CT imaging systems
•Nuclear imaging
oMicro-PET systems (standalone PET, PET/CT, and PET/MRI)
oMicro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)
oTri-modality (PET/SPECT/CT) imaging systems
• Micro-MRI
• Micro-CT
• Micro-ultrasound
• Photoacoustic
• Magnetic particle imaging systems
2. By Reagents
•Optical imaging reagents
oBioluminescent reagents
oFluorescent imaging reagents
•Nuclear imaging reagents
oPreclinical PET tracers
oPreclinical SPECT probes
•MRI contrast agents
•Ultrasound contrast agents
•CT contrast agents
Geographically, the market for Preclinical in-vivo imaging market is segmented as below:
•North America
•Europe
•Asia-Pacific
•Latin America
•Middle-East and Africa
Enquire before buying at http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/inquire
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the global preclinical imaging systems market.
Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-preclinical-in-vivo-imaging-market-582
About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
